In a preclinical study, Naumov et al. reported that EGFR-TKI resistant (primary resistant or T790M positive) cells highly secreted VEGF and that EGFR-TKI resistance could be associated with VEGF elevation in both the tumor cells and host stroma [23]. This evidence concerns the gene EGFR and neoplasm.